Amy Wilson

Vice President, Chief Compliance Officer at Esperion Therapeutics

Amy Wilson has a diverse work experience in the pharmaceutical industry. Amy currently serves as the Vice President and Chief Compliance Officer at Esperion. Prior to that, they were the Head of U.S. Compliance at MorphoSys, where they built a compliance management program and fostered a culture of integrity. Amy also worked as the Director of Enterprise Compliance at Alexion Pharmaceuticals and as the Director of US Compliance Monitoring and Risk Management Lead at Shire. Amy has held various roles at Novartis Pharmaceuticals and Novartis Oncology, including Marketing Operations and Compliance Lead and Associate Brand Director. Amy started their career as a Specialty Sales Representative at Eisai Pharmaceuticals and later became a Senior Product Manager. Overall, Amy has a strong background in compliance and risk management in the pharmaceutical industry.

Amy Wilson has a strong educational background in the field of law and compliance, with a focus on the life sciences industry. In 2013, they obtained a Certificate in Compliance in the Life Sciences from Seton Hall University School of Law, specializing in pharmaceutical law. Amy further pursued their education at Seton Hall University School of Law, earning a Master's of Science in Jurisprudence from 2014 to 2016, with a concentration in Life Sciences Law and Compliance.

Prior to their law studies, Amy pursued a Master of Business Administration (MBA) degree from Fairleigh Dickinson University from 2003 to 2005. Amy specialized in finance and pharmaceuticals during their MBA studies. Amy's educational journey commenced at Drexel University's LeBow College of Business, where they earned a Bachelor of Science (BS) degree from 1990 to 1995. Their undergraduate studies focused on marketing and international business.

In summary, Amy Wilson has a comprehensive education history, encompassing a Certificate in Compliance in the Life Sciences, a Master's of Science in Jurisprudence, an MBA specializing in finance and pharmaceuticals, and a Bachelor's degree with a concentration in marketing and international business.

Links

Previous companies

Alexion Pharmaceuticals logo
Novartis logo
MorphoSys logo

Timeline

  • Vice President, Chief Compliance Officer

    January, 2022 - present

View in org chart